LADENBURG THALMANN FINANCIAL SERVICES INC. - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRV and the CUSIP is 21234W202. A total of 20 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$1,0000.0%3,2800.0%0.00%
Q4 2018$1,000
-50.0%
3,2800.0%0.00%
Q3 2018$2,0003,2800.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Prospera Financial Services Inc 16,323$4,0000.00%
JPMORGAN CHASE & CO 87$00.00%
BARCLAYS PLC 84,034$19,0000.00%
ROYAL BANK OF CANADA 7$00.00%
VANGUARD GROUP INC 101,131$23,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 3,280$1,0000.00%
Capital Advisors, Ltd. LLC 22$00.00%
UBS Group AG 3,112$1,0000.00%
Advisor Group, Inc. 35$00.00%
BANK OF AMERICA CORP /DE/ 336$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders